About Atomwise
Atomwise uses a machine learning platform to discover novel, drug-like molecules. Its programs deliver potential in immune and inflammatory diseases. Atomwise offers a machine learning-based drug discovery service.
Sectors & Market Categories
Company Details
Corporate & Operational Profile
Primary Industry
Biotech & Healthcare
Funding Stage
Series-B+
Global Headquarters
Undisclosed
Year Founded
2012
Tracked Since
Oct 1, 2026
Web & Domain Identity
Official Website
atomwise.com
Domain Registered Date
Dec 17, 2012
Social & Network Presence
X / Twitter Profile
Not linked
LinkedIn Corporate
Not linked
Company Milestones & Timeline
- Capital Raise
Series-B+ announced
startupintros.com
- Capital Raise
Raised $120,000,000 · Series-B+
startupintros.com
- Capital Raise
Raised $45,000,000 · Series-A
startupintros.com
- Capital Raise
Raised $6,000,000 · Seed
startupintros.com
- Milestone
Website domain registered
atomwise.com
- Milestone
Company founded
Investors & Backers
Investor firms and individual backers were not publicly disclosed in available round filings for Atomwise.
Funding History
Series-B+
· Mar 18, 2025
Undisclosed startupintros.com
Series-B+
· Aug 1, 2020
$120,000,000 startupintros.com
Series-A
· Mar 1, 2018
$45,000,000 startupintros.com
Seed
· Jun 1, 2015
$6,000,000 startupintros.com
Founders & Leadership
Abraham Heifets
Co-Founder and CEO
Work email & phone locked
Unlock →
Press Coverage & Sources
Recently Funded Biotech & Healthcare Startups
View allVitalls
vitalls.ai
Seed Abu Dhabi, United Arab Emirates · Oct 2026
Hexagon Bio
hexagonbio.com
Series-B+ Oct 2026
RefloDx
reflodx.com
Seed Kaysville, United States · Oct 2026
HeyVoli
heyvoli.com
Pre-Seed Bangalore, India · Oct 2026
CureBay
curebay.com
Series-B+ Bhubaneshwar, India · Oct 2026
4Tissue
4tissue.com
Series-A Ghent, Belgium · Oct 2026